{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:42Z","timestamp":1767135402378,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":56,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001917.pub3","type":"reference-entry","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T10:39:29Z","timestamp":1331289569000},"source":"Crossref","is-referenced-by-count":5,"title":["Home versus hospital intravenous antibiotic therapy for cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Albert","family":"Balaguer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Gonz\u00e1lez de Dios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,14]]},"reference":[{"key":"10.1002\/14651858.CD001917.pub3-BIB1|cit1","first-page":"567","article-title":"Intravenous home therapy: a randomised trial in adult cystic fibrosis patients [abstract]","volume":"25","author":"Wolter","year":"1995","journal-title":"Australian & New Zealand Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001917.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1183\/09031936.97.10040896","article-title":"Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects","volume":"10","author":"Wolter","year":"1997","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001917.pub3-BIB3|cit3","first-page":"123s","article-title":"Home intravenous therapy in adult cystic fibrosis patients. The impact on lung fuction and quality of life [abstract]","volume":"Suppl 31","author":"Amelina","year":"2000","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD001917.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1099-0496(199707)24:1<42::AID-PPUL7>3.0.CO;2-L","article-title":"Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis","volume":"24","author":"Bosworth","year":"1997","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD001917.pub3-BIB5|cit5","first-page":"207","article-title":"A randomized trial of home intravenous antibiotic therapy (HIVAT) in Cystic Fibrosis (CF): Short-Term Safety and efficacy [abstract]","volume":"Suppl 5","author":"Davis","year":"1990","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD001917.pub3-BIB6|cit6","first-page":"338","article-title":"A randomized trial of home intravenous antibiotic therapy (HIVAT) in Cystic Fibrosis (CF): Short-Term psychological effects [abstract]","volume":"Suppl 5","author":"Davis","year":"1990","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD001917.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3476(87)80337-2","article-title":"Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease","volume":"111","author":"Donati","year":"1987","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001917.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2702.2005.01236.x","article-title":"Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis","volume":"15","author":"Esmond","year":"2006","journal-title":"Journal of Clinical Nursing"},{"issue":"17","key":"10.1002\/14651858.CD001917.pub3-BIB9|cit9","first-page":"648","article-title":"Home intravenous antibiotic treatments in cystic fibrosis units of Madrid","volume":"122","author":"Gir\u00f3n","year":"2004","journal-title":"Medicina cl\u00ednica"},{"issue":"15","key":"10.1002\/14651858.CD001917.pub3-BIB10|cit10","first-page":"567","article-title":"Efficiency of the home intravenous antibiotics treatment in cystic fibrosis","volume":"127","author":"Gir\u00f3n","year":"2006","journal-title":"Medicina cl\u00ednica"},{"issue":"10","key":"10.1002\/14651858.CD001917.pub3-BIB11|cit11","first-page":"626","article-title":"Economic aspects in treatment of cystic fibrosis with chronic pulmonary pseudomonas infection. Ambulatory intarvenous therapy in comparison with inpatient treatment","volume":"92","author":"Graf von der Schulenburg","year":"1997","journal-title":"Medizinische Klinik"},{"issue":"1","key":"10.1002\/14651858.CD001917.pub3-BIB12|cit12","first-page":"31","article-title":"Ambulatory vs. inpatient intravenous antibiotic therapy in mucoviscidosis patients - a controlled study","volume":"53","author":"Klettke","year":"1999","journal-title":"Pneumologie"},{"key":"10.1002\/14651858.CD001917.pub3-BIB13|cit13","first-page":"1047","article-title":"Home intravenous antibiotic therapy vs. hospital therapy - an alternative for patients with cystic fibrosis?","volume":"144","author":"Magdorf","year":"1996","journal-title":"Monatsschrift Fur Kinderheilkunde"},{"issue":"4","key":"10.1002\/14651858.CD001917.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1017\/S0266462306051476","article-title":"Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France","volume":"22","author":"Horvais","year":"2006","journal-title":"International journal of technology assessment in health care"},{"issue":"8","key":"10.1002\/14651858.CD001917.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ppul.20433","article-title":"Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis","volume":"41","author":"Nazer","year":"2006","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD001917.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2710.2000.00319.x","article-title":"Pharmaceutical intervention in the care of cystic fibrosis patients","volume":"25","author":"Ramstr\u00f6m","year":"2000","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD001917.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s15010-002-2095-0","article-title":"Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis","volume":"30","author":"Riethmueller","year":"2002","journal-title":"Infection"},{"issue":"5","key":"10.1002\/14651858.CD001917.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s15010-009-8117-4","article-title":"Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"key":"10.1002\/14651858.CD001917.pub3-BIB19|cit19","series-title":"Proceedings of the 13th International Cystic Fibrosis Congress; 2000 June 4-8; Stockholm, Sweden","first-page":"166","article-title":"Pharmacodynamic variation of intravenous antibiotic treatment with ceftazidime and tobramycin in CF-patients is equally effective [abstract]","author":"Riethmueller","year":"2000"},{"key":"10.1002\/14651858.CD001917.pub3-BIB20|cit20","series-title":"Proceedings of the 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria","first-page":"P192","article-title":"Optimised intravenous antibiotic treatment with ceftazidime (thrice daily vs continuous) and tobramycin (thrice vs once daily) in CF patients [abstract]","author":"Riethmueller","year":"2001"},{"issue":"5","key":"10.1002\/14651858.CD001917.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s15010-009-8116-5","article-title":"Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"issue":"Suppl 24","key":"10.1002\/14651858.CD001917.pub3-BIB22|cit22","first-page":"289","article-title":"Acute-phase nephrotoxicity of tobramycin in CF patients: A prospective randomized trial of once-versus thrice-daily dosing [abstract]","volume":"34","author":"Schroeter","year":"2002","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD001917.pub3-BIB23|cit23","series-title":"Proceedings of the 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria","first-page":"P190","article-title":"A prospective randomized trial on the nephrotoxicity of thrice-daily versus once-daily tobramycin in cystic fibrosis patients [abstract]","author":"Schroeter","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB24|cit24","first-page":"79","article-title":"Ofloxacin in the treatment of cystic fibrosis","volume":"44","author":"Romano","year":"1992","journal-title":"Minerva Pediatrica"},{"issue":"13","key":"10.1002\/14651858.CD001917.pub3-BIB25|cit25","first-page":"181","article-title":"Role of home therapy with ofloxacin in patients with cystic fibrosis (CF)","volume":"38","author":"Romano","year":"1991","journal-title":"Giornale Italiano de Chemioterapia"},{"issue":"4","key":"10.1002\/14651858.CD001917.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1017\/S0266462305050701","article-title":"Comparing costs of home- versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center","volume":"21","author":"Elliott","year":"2005","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/thx.2003.005876","article-title":"Free Full TextLong term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis","volume":"59","author":"Thornton","year":"2004","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD001917.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcf.2005.08.003","article-title":"Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: comparing hospital and home care","volume":"4","author":"Thornton","year":"2005","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0163-4453(03)00135-X","article-title":"A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases","volume":"48","author":"Wolter","year":"2004","journal-title":"Journal of Infection"},{"key":"10.1002\/14651858.CD001917.pub3-BIB30|cit30","unstructured":"Hjelte L Widen B Malmborg AS Freyschuss U Strandvik B [Intravenous administration of antibiotics at home in patients with cystic fibrosis improves quality of life] Lakartidningen 1988 1614 7"},{"issue":"6","key":"10.1002\/14651858.CD001917.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2362.2000.00667.x","article-title":"Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis","volume":"30","author":"Bell","year":"2000","journal-title":"European Journal of Clinical Investigation"},{"issue":"9","key":"10.1002\/14651858.CD001917.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1164\/rccm.201001-0057OC","article-title":"Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes","volume":"182","author":"Collaco","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"23","key":"10.1002\/14651858.CD001917.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2386-92","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/014107688908200303","article-title":"Intravenous antibiotics at home in children with cystic fibrosis","volume":"82","author":"David","year":"1986","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7109","key":"10.1002\/14651858.CD001917.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9","key":"10.1002\/14651858.CD001917.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001917.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.63.5.512","article-title":"Home intravenous antibiotic treatment in cystic fibrosis","volume":"63","author":"Gilbert","year":"1988","journal-title":"Archives of Disease in Childhood"},{"issue":"8","key":"10.1002\/14651858.CD001917.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/adc.2009.162222","article-title":"A review of the home intravenous antibiotic service available to children with cystic fibrosis","volume":"94","author":"Gilchrist","year":"2009","journal-title":"Archives of Disease in Childhood"},{"issue":"Pt 4","key":"10.1002\/14651858.CD001917.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1099\/mic.0.2006\/004077-0","article-title":"Microbial ecology of the cystic fibrosis lung","volume":"153","author":"Harrison","year":"2007","journal-title":"Microbiology"},{"issue":"7414","key":"10.1002\/14651858.CD001917.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"Suppl 43","key":"10.1002\/14651858.CD001917.pub3-BIB43|cit43","first-page":"66","article-title":"Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and pandoraea spp","volume":"96","author":"Jones","year":"2003","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"7303","key":"10.1002\/14651858.CD001917.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD001917.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X","article-title":"The incidence of cystic fibrosis","volume":"15","author":"Kosorok","year":"1996","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001917.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD001917.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1002\/14651858.CD001917.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1183\/09031936.94.07091640","article-title":"Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis","volume":"7","author":"Pond","year":"1994","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD001917.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.rmed.2008.08.017","article-title":"Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior","volume":"103","author":"Proesmans","year":"2009","journal-title":"Respiratory Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1542\/peds.54.3.358","article-title":"Outpatient intravenous medication in the management of cystic fibrosis","volume":"54","author":"Rucker","year":"1974","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001917.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD001917.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/1817-1737.53346","article-title":"Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis - Is it good for the patient?","volume":"4","author":"Sequeiros","year":"2009","journal-title":"Annals of Thoracic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001917.pub3-BIB53|cit53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007491","article-title":"Hospital at home admission avoidance","author":"Shepperd","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001917.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1651-2227.1992.tb12239.x","article-title":"Home intravenous antibiotic treatment of patients with cystic fibrosis","volume":"81","author":"Strandvik","year":"1992","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD001917.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0924-8579(94)00060-8","article-title":"Cystic fibrosis and outpatient treatment with parenteral antibiotics in children","volume":"5","author":"Laag","year":"1995","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"5","key":"10.1002\/14651858.CD001917.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1164\/rccm.201009-1392OC","article-title":"Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease","volume":"183","author":"Waters","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001917.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T00:00:00Z","timestamp":1450137600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001917.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T20:28:19Z","timestamp":1687292899000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001917.pub3"}},"subtitle":[],"editor":[{"given":"Albert","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,14]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001917.pub3","relation":{},"subject":[],"published":{"date-parts":[[2012,3,14]]}}}